SeraCare™ ACCURUN™ 676 Cystic Fibrosis Extended Control

Description

A synthetic, multiplex control formulated for research use in laboratory testing, molecular screening, and mutation testing, with assays that identify mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene

• Eliminates errors arising from use of rotating gDNA control schemes with incomplete mutation profiles
• Controls contain a mixture of oligonucleotides that produce a call for every mutation tested
• ACCURUN 676 covers 34 mutations, and when used in conjunction with ACCURUN 644, covers all 81 mutations in the Prima xTAG™ CFTR 70+6 Assay
• All mutations contained in a single vial
• High purity, large lots, stable materials–no additional processing required

Not for use in diagnostic procedures

Specifications

• Certifications/Compliance: RUO
• Type: ACCURUN 676 Cystic Fibrosis Extended Control
• Intended Use: Detects significant errors with the use of rotating gDNA control schemes, research use only
• Quantity: 100 μL